BRICS News Magazine
Login Cart Register
An MIT report that 95% of AI pilots fail spooked investors. But it’s the reason why those pilots failed that should make the C-suite anxious
Finance

An MIT report that 95% of AI pilots fail spooked investors. But it’s the reason why those pilots failed that should make the C-suite anxious

Claire Dubois 208 views
Editor's Choice Featured

An MIT report that 95% of AI pilots fail spooked investors. But the reason why those pilots failed is what should make the C-suite anxious

You’re doing it wrong

Buy, don’t build

FORTUNE ON AI

AI IN THE NEWS

AI CALENDAR

EYE ON AI NUMBERS

100%

Jeremy Kahn is the AI editor at Fortune, spearheading the publication's coverage of artificial intelligence. He also co-

Hello and welcome to Eye on AI…In this edition: DeepSeek drops another impressive model…China tells companies not to buy Nvidia chips…and OpenEvidence scores an impressive result on the medical licensing exam.Hi, it’s Jeremy here, just back from a few weeks of much needed vacation. It was nice to be able to get a little distance and perspective on the AI news cycle. (Although I did make an appearance on Rana el Kaliouby’s “Pioneers of AI” podcast to discuss the launch of GPT-5. You can check that out here.)Returning this week, the news has been all about investor fears we’re in an “AI bubble”—and that it is about to either pop or deflate. Nervous investors drove the shares of many publicly-traded tech companies linked to AI-related trades, such as Nvidia, CoreWeave, Microsoft, and Alphabet down significantly this week.To me, one of the clearest signs that we are in a bubble—at least in terms of publicly-traded AI stocks—is the extent to which investors are actively looking for reasons to bail. Take the supposed rationale for this week’s sell-off, which were Altman’s comments that he thought there was an AI bubble in venture-backed, privately-held AI startups and that MIT report which found that 95% of AI pilots fail. Altman wasn’t talking about the public companies that stock market investors have in their portfolios, but traders didn’t care. They chose to only read the headlines and interpret Altman’s remarks broadly. As for that MIT report, the market chose to read it as an indictment of AI as a whole and head for the exits—even though that’s not exactly what the research said, as we’ll see in a moment.I’m going to spend the rest of this essay on the MIT report because I think it is relevant for Eye on AI readers beyond its implications for investors. The report looked at what companies are actually trying to do with AI and why they may not be succeeding. Entitled The GenAI Divide: State of AI in Business 2025, the report was published

Ok, now let’s look at what the report actually says. It interviewed 150 executives, surveyed 350 employees, and looked at 300 individual AI projects. It found that 95% of AI pilot projects failed to deliver any discernible financial savings or uplift in profits. These findings are not actually all that different from what a lot of previous surveys have found—and those surveys had no negative impact on the stock market. Consulting firm Capgemini found in 2023 that 88% of AI pilots failed to reach production. (S&P Global found earlier this year that 42% of generative AI pilots were abandoned—which is still not great).

But where it gets interesting is what the NANDA study said about the apparent reasons for these failures. The biggest problem, the report found, was not that the AI models weren’t capable enough (although execs tended to think that was the problem.) Instead, the researchers discovered a “learning gap—people and organizations simply did not understand how to use the AI tools properly or how to design workflows that could capture the benefits of AI while minimizing downside risks.Large language models seem simple—you can give them instructions in plain language, after all. But it takes expertise and experimentation to embed them in business workflows. Wharton professor Ethan Mollick has suggested that the real benefits of AI will come when companies abandon trying to get AI models to follow existing processes—many of which he argues reflect bureaucracy and office politics more than anything else—and simply let the models find their own way to produce the desired business outcomes. (I think Mollick underestimates the extent to which processes in many large companies reflect regulatory demands, but he no doubt has a point in many cases.)This phenomenon may also explain why the MIT NANDA research found that startups, which often don’t have such entrenched business processes to begin with, are much more likely to find genAI can deliver ROI.

The report also found that companies which bought-in AI models and solutions were more successful than enterprises that tried to build their own systems. Purchasing AI tools succeeded 67% of the time, while internal builds panned out only one-third as often. Some large organizations, especially in regulated industries, feel they have to build their own tools for legal and data privacy reasons. But in some cases organizations fetishize control—when they would be better off handing the hard work off to a vendor whose entire business is creating AI software.Building AI models or systems from scratch requires a level of expertise many companies don’t have and can’t afford to hire. It is also means that companies are building their AI systems on open

With that, here’s the rest of the AI news.

Jeremy Kahnjeremy.kahn.com

Why the NFL drafted Microsoft’s gen AI for the league’s next big play—

China moves to restrict Nvidia H20 sales after Lutnick remarks. That’s according a story in the Financial Times that said Beijing had found U.S. Commerce Secretary Howard Lutnick’s comments that the U.S. was withholding its best technology from China to be “insulting.” CAC, China’s internet regulator, issued an informal notice to major tech companies such as

DeepSeek launches its V3.1 model to enthusiastic reviews. The Chinese frontier AI company released an updated version of its powerful V3 LLM open

Google unveils its latest Pixel phones full of AI features. Google unveiled its Pixel 10 smartphone lineup, heavily centered on its Gemini AI assistant. The phones have features such as “Magic Cue” that provides suggested next actions based on contextual information, an AI “Camera Coach” for smarter photography, and Gemini Live for real-time screen interactions. The new AI features may allow Google to gain some marketshare from Apple, which has delayed the roll-out of many AI features for its iPhones until 2026. You can read more from CNBC here.OpenAI considers renting AI infrastructure to others. OpenAI CFO Sara Friar told Bloomberg that the company is considering renting out AI-optimized data centers and infrastructure to other companies in the future, similar to Amazon’s AWS—even though OpenAI currently struggles to find enough data center capacity for its own operations. Friar also said the company is exploring financing options beyond debt as it faces immense costs, with CEO Sam Altman predicting trillions of dollars in future data center spending. Friar also confirmed in an interview with CNBC that the company recently hit $1 billion in monthly revenue for the first time, while Bloomberg reported that secondary share sales have valued the company at $500 billion.

Sept. 8-10: Fortune Brainstorm Tech, Park City, Utah. Apply to attend here.

Oct. 6-10: World AI Week, Amsterdam

Oct. 21-22: TedAI San Francisco. Apply to attend here.

Dec. 2-7: NeurIPS, San Diego

Dec. 8-9: Fortune Brainstorm AI San Francisco. Apply to attend here.

That’s the score medical AI startup OpenEvidence says its new AI model achieved on the U.S. Medical Licensing Exam (USMLE), the three-part exam all new doctors must take before they can practice. This beats the 90% its model scored two years ago as well as the 97% that OpenAI’s GPT-5 recently scored. OpenEvidence says its model offers case-based, literature-grounded explanations for its answers and the startup is offering the model to medical students as a free educational tool through a partnership with the American Medical Association, its associated journal, and the New England Journal of Medicine. You can read more from the healthcare-focused publication Fierce Healthcare here.

About the Author

Claire

Claire Dubois

View all articles

Comments (0)

Sign in to Comment

Join the discussion and share your thoughts on this article.

Sign In

No Comments Yet

Be the first to share your thoughts on this article!

diş beyazlatma